Answers are grounded in this paper and cite their sources.
Introduction: Ultra-late isolated parasternal recurrence after triple-negative breast cancer is uncommon. When a lesion crosses the regional nodal basin, soft tissues, ribs, and sternum, its anatomical origin and oncological classification may be uncertain. Case Presentation: A 66-year-old woman presented with a painful left parasternal mass 19 years after treatment for triple-negative left breast cancer. Computed tomography showed a 47 x 35 x 30 mm lesion centered at the anterior third and fourth ribs near their articulation with the sternum, with destruction of the adjacent costal cartilage; positron emission tomography-computed tomography showed no other disease. Core needle biopsy confirmed breast carcinoma with estrogen receptor expression in 100% of tumor cells, progesterone receptor expression below 1%, a human epidermal growth factor receptor 2 immunohistochemistry score of 1+, and a Ki-67 proliferation index of up to 10%. The patient underwent en bloc sternocostal resection followed by immediate reconstruction with a patient-specific three-dimensional-printed titanium implant. Histopathology confirmed clear resection margins. The multidisciplinary assessment considered a regional parasternal nodal recurrence with direct sternocostal involvement most likely, although the exact site of origin could not be established histologically. She was discharged on postoperative day 8. Letrozole was subsequently replaced with anastrozole because of intolerance and hypertension. Conclusion: Re-biopsy of an ultra-late isolated parasternal recurrence demonstrated a marked change in hormone receptor status and enabled endocrine therapy. En bloc resection with patient-specific titanium reconstruction was technically feasible and achieved uncomplicated early recovery. The distinction between a regional nodal recurrence with direct chest-wall invasion and a solitary osseous metastasis remained uncertain. Longer follow-up is required to assess oncological control and implant durability.
No takes yet. Share an insight, caveat, or question.
Piovar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: